Chengdu New Hengchuang Pharmaceutical

Chengdu New Hengchuang Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company focuses primarily on chronic disease management, with a strong portfolio in cardiovascular, metabolic, and endocrine therapeutic areas. Operating as both a manufacturer of its own products and a contract development and manufacturing organization (CDMO), it maintains high-standard production facilities that comply with international GMP requirements. Its product line includes various generic medications such as antihypertensives and glucose-lowering agents, serving both domestic and international markets.